Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.
Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.